tradingkey.logo
tradingkey.logo

Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic Protoporphyria

ReutersMar 26, 2026 8:48 PM

- Disc Medicine Inc IRON.O:

  • DISC MEDICINE ANNOUNCES COMPLETION OF ENROLLMENT OF PHASE 3 APOLLO TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA

  • DISC MEDICINE INC - APOLLO STUDY RESULTS EXPECTED IN Q4 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI